Position in AVIR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,511,860
+$364,428 QoQ
Shares Held
755,239
+29.1% QoQ
Ownership
0.942%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. AVIR ranks #191 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,511,860 | 755,239 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,147,432 | 585,025 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,999,977 | 560,218 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,851,324 | 638,388 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,431,651 | 675,459 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,063,622 | 690,175 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,361,443 | 704,909 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,302,916 | 687,438 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,188,848 | 661,284 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,776,564 | 687,269 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,170,113 | 711,513 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,998,456 | 666,152 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,418,818 | 646,743 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,361,896 | 705,044 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,419,610 | 710,938 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,126,534 | 725,226 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,921,194 | 693,126 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,043,343 | 560,020 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,142,895 | 575,268 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $20,733,115 | 591,361 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,178,663 | 520,422 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,322,128 | 167,160 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,391,089 | 176,905 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||